ApoB Test May More Accurately Measure Heart Disease Risk
A study reveals that lipid panels may not fully capture the risk of cholesterol-related heart disease, highlighting a need for apoB testing.
Read MorePosted by Andy Lundin | Aug 13, 2024 | Cardiovascular |
A study reveals that lipid panels may not fully capture the risk of cholesterol-related heart disease, highlighting a need for apoB testing.
Read MorePosted by Chris Wolski | Jul 3, 2024 | Specimen Collection & Handling |
Lab values predict the risk of periprosthetic joint infection (PJI) in severely obese patients undergoing knee or hip replacement.
Read MorePosted by Chris Wolski | May 16, 2024 | Diabetes & Metabolic Diseases |
Luxor Scientific and CIMA Sciences have launched OWLiver, a non-invasive blood test to detect all stages of metabolic liver disease.
Read MorePosted by Andy Lundin | Mar 21, 2024 | Gastrointestinal Infections |
Lucid Diagnostics announced that a prospective VA screening study demonstrated strong performance of its EsoGuard Esophageal DNA test.
Read MorePosted by Andy Lundin | Jan 12, 2024 | Unknown Origin & Other Cancer Types |
Individuals with obesity are more likely to have MGUS, a benign blood condition that often precedes multiple myeloma.
Read More